Jun Jia Selected Research

Oxaliplatin (Eloxatin)

1/2019	The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer.
10/2016	[Difference analysis of chemotherapy efficacy among different primary tumor sites in metastatic colorectal cancer].
1/2016	The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Jia Research Topics

Disease

55	Neoplasms (Cancer) 05/2024 - 11/2005
16	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2008
13	Parkinson Disease (Parkinson's Disease) 01/2022 - 09/2009
11	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2005
9	Glioma (Gliomas) 07/2021 - 06/2018
8	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2011
8	Squamous Cell Carcinoma of Head and Neck 02/2023 - 05/2011
8	Esophageal Squamous Cell Carcinoma 01/2022 - 04/2016
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 08/2012
6	Wounds and Injuries (Trauma) 02/2024 - 11/2004
6	Carcinogenesis 02/2023 - 06/2013
6	Hemangioma (Angioma) 12/2015 - 01/2007
5	Hypoxia (Hypoxemia) 04/2024 - 01/2010
5	Infections 07/2023 - 05/2015
4	Burns 02/2024 - 12/2014
4	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 01/2019
4	Disease Progression 04/2023 - 09/2019
4	Inflammation (Inflammations) 01/2022 - 10/2012
4	Adenoid Cystic Carcinoma (Cylindroma) 02/2013 - 08/2010
3	Lymphatic Metastasis 01/2024 - 01/2017
3	Carcinoma (Carcinomatosis) 04/2023 - 11/2005
3	Mouth Neoplasms (Oral Cancer) 01/2023 - 05/2011
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 04/2015
3	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2016
3	Pain (Aches) 05/2016 - 11/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2015 - 09/2009
2	Colonic Neoplasms (Colon Cancer) 04/2023 - 06/2018
2	Cataract (Cataracts) 01/2022 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2013
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Nasopharyngeal Carcinoma 10/2021 - 10/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2019
2	Diarrhea 09/2019 - 05/2015
2	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2019 - 10/2017
2	Heart Failure 04/2017 - 01/2014
2	Neutropenia 10/2016 - 05/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2008
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2012
7	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 01/2016
6	RNA (Ribonucleic Acid)IBA 02/2023 - 11/2005
6	Messenger RNA (mRNA)IBA 01/2021 - 07/2008
5	Immune Checkpoint InhibitorsIBA 04/2024 - 12/2019
5	HydrogelsIBA 07/2021 - 01/2020
5	Long Noncoding RNAIBA 01/2021 - 01/2018
4	Oxygen (Dioxygen)IBA 07/2023 - 08/2004
4	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2011
4	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 10/2016
4	Temozolomide (Temodar)FDA LinkGeneric 02/2021 - 01/2020
4	EnzymesIBA 02/2021 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 12/2020 - 01/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 01/2011
3	MethyltransferasesIBA 01/2024 - 01/2011
3	Therapeutic UsesIBA 01/2024 - 01/2013
3	Tumor Biomarkers (Tumor Markers)IBA 04/2023 - 01/2019
3	CytokinesIBA 01/2023 - 02/2013
3	taxaneIBA 01/2022 - 05/2015
3	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2021 - 10/2016
3	Gefitinib (Iressa)FDA Link 01/2020 - 01/2012
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 10/2008
3	PlatinumIBA 01/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2013
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2016
3	RNA Splicing FactorsIBA 01/2019 - 09/2015
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 10/2013 - 01/2011
3	TOR Serine-Threonine KinasesIBA 06/2013 - 08/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 01/2010
3	Docetaxel (Taxotere)FDA Link 07/2012 - 02/2011
2	Retinaldehyde (Retinal)IBA 05/2023 - 07/2016
2	Protein Isoforms (Isoforms)IBA 02/2023 - 01/2023
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2023 - 09/2015
2	Gemcitabine FDA Link 10/2021 - 10/2016
2	Tyrosine Kinase InhibitorsIBA 05/2021 - 01/2020
2	apatinibIBA 02/2021 - 01/2020
2	CopperIBA 01/2021 - 01/2019
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2020 - 07/2008
2	Oxidopamine (6 Hydroxydopamine)IBA 09/2020 - 01/2018
2	Circular RNAIBA 01/2020 - 06/2018
2	Angiopep-2IBA 01/2020 - 09/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2011
2	AntigensIBA 12/2019 - 04/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 12/2015
2	nimotuzumabIBA 01/2019 - 04/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2017 - 01/2014
2	pro-brain natriuretic peptide (1-76)IBA 04/2017 - 01/2014
2	ParaffinIBA 03/2016 - 10/2008

Therapy/Procedure

25	Therapeutics 07/2023 - 06/2005
18	Drug Therapy (Chemotherapy) 01/2023 - 01/2011
11	Immunotherapy 04/2024 - 11/2005
8	Electroacupuncture 09/2020 - 01/2012
6	Radiotherapy 12/2023 - 03/2015
5	Injections 07/2021 - 05/2016
3	Free Tissue Flaps 05/2024 - 01/2023
3	Skin Transplantation (Skin Grafting) 02/2016 - 12/2014
2	Phacoemulsification 01/2022 - 01/2021
2	Deep Brain Stimulation 01/2019 - 01/2018